Holocene Advisors, LP Verona Pharma PLC Transaction History
Holocene Advisors, LP
- $31.7 Billion
- Q1 2025
A detailed history of Holocene Advisors, LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Holocene Advisors, LP holds 1,366,680 shares of VRNA stock, worth $144 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,366,680Holding current value
$144 Million% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
297Shares Held
73.5MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$692 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$581 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$414 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$364 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$305 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.42B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...